Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Composés actifs
Mécanisme d'action
Preuves cliniques
Type 3 resistant starch (Ce-RS3) significantly decreased levels of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol over 12 weeks [PMID:38825157].
Acylated Canna edulis starch (butyrylated and valeroylated) improved metrics of weight reduction, blood glucose, insulin resistance, and lipid metabolism in animal models [PMID:40829682].
Canna starch intake prevented the decrease in body temperature associated with anaphylactic response in ovalbumin-induced food allergy mice [PMID:38397452].
Canna edulis RS3 significantly reduced climbing time and alleviated neuroinflammation and apoptosis in the substantia nigra [PMID:39347419].
Posologie et administration
Synthèse des preuves
Sources PubMed
- 1.PMID: 39447808 (2024) — Structural, morphological, compositional, thermal, pasting, and functional properties of isolated Achira (Canna indica L.) starch: Review. · International journal of biological macromolecules
- 2.PMID: 19627148 (2009) — Characterization of starch from two ecotypes of andean achira roots (Canna edulis). · Journal of agricultural and food chemistry
- 3.PMID: 33678878 (2021) — Dual modification of achira (Canna indica L) starch and the effect on its physicochemical properties for possible food applications. · Journal of food science and technology
- 4.PMID: 16187013 (2005) — Chemical composition, mineral profile, and functional properties of Canna (Canna edulis) and Arrowroot (Maranta spp.) starches. · Plant foods for human nutrition (Dordrecht, Netherlands)
- 5.PMID: 37016689